Skip to main content
. Author manuscript; available in PMC: 2023 May 15.
Published in final edited form as: Int J Cancer. 2022 Jan 18;150(10):1599–1608. doi: 10.1002/ijc.33925

Table 3.

Association Between Diet Composite Dietary Antioxidant Index (CDAI) and the Risk of Colorectal Cancer (CRC) Stratified by Selected Characteristics in the Singapore Chinese Health Study, 1993–2015

CDAI in quartile Person-year CRC Cases HR (95% CI)a

By Diabetes History
No history of type 2 diabetes
 Q1 (−13.3, −4.9) 237,453 525 1.00
 Q2 (−4.9, −2.3) 248,794 505 0.96 (0.84–1.09)
 Q3 (−2.3, 1.0) 253,902 459 0.84 (0.72–0.98)
 Q4 (1.0, 58.6) 256,831 453 0.77 (0.62–0.94)
Ptrend 0.007
 Continuous scale (per SDb) 0.93 (0.84, 1.04)
Had history of type 2 diabetes
 Q1 (−12.1, −4.9) 20,787 57 1.00
 Q2 (−4.9, −2.3) 19,633 40 0.78 (0.50–1.20)
 Q3 (−2.3, 1.0) 17,960 48 1.04 (0.65–1.67)
 Q4 (1.0, 37.2) 19,000 53 1.18 (0.63–2.20)
Ptrend 0.51
 Continuous scale (per SD) 0.81 (0.59–1.11)
Pheterogeneity 0.16
By BMI Level
BMI<23 kg/m2
 Q1 (−13.0, −4.9) 117,670 263 1.00
 Q2 (−4.9, −2.3) 128,101 259 0.96 (0.80–1.15)
 Q3 (−2.3, 1.0) 132,431 258 0.96 (0.78–1.19)
 Q4 (1.0, 58.6) 134,609 248 0.87 (0.65–1.16)
Ptrend 0.43
 Continuous scale (per SD) 0.96 (0.84–1.11)
BMI ≥23 kg/m2
 Q1 (−13.3, −4.9) 140,570 319 1.00
 Q2 (−4.9, −2.3) 140,326 286 0.93 (0.78–1.10)
 Q3 (−2.3, 1.0) 139,431 249 0.78 (0.64–0.96)
 Q4 (1.0, 55.1) 141,222 258 0.75 (0.57–0.99)
Ptrend 0.01
 Continuous scale (per SD) 0.88 (0.76–1.01)
Pheterogeneity 0.37
By Smoking Status
Never Smokers
 Q1 (−13.3, −4.9) 191,506 385 1.00
 Q2 (−4.9, −2.3) 199,601 358 0.93 (0.80–1.09)
 Q3 (−2.3, 1.0) 196,040 318 0.83 (0.69–0.99)
 Q4 (1.0, 58.6) 190,259 288 0.69 (0.54–0.89)
Ptrend 0.005
 Continuous scale (per SD) 0.90 (0.79–1.02)
Ever Smokers
 Q1 (−13.0, −4.9) 66,733 197 1.00
 Q2 (−4.9, −2.3) 68,826 187 0.96 (0.78–1.19)
 Q3 (−2.3, 1.0) 75,822 189 0.93 (0.73–1.19)
 Q4 (1.0, 46.4) 85,572 218 1.01 (0.73–1.40)
Ptrend 0.92
 Continuous scale (per SD) 0.98 (0.83–1.15)
Pheterogeneity 0.35
By Family History of CRC
No
 Q1 (−13.3, −4.9) 253,917 567 1.00
 Q2 (−4.9, −2.3) 262,598 540 0.97 (0.86–1.10)
 Q3 (−2.3,1.0) 265,244 484 0.86 (0.74–0.99)
 Q4 (1.0,58.6) 268,337 482 0.80 (0.65–0.97)
Ptrend 0.01
 Continuous scale (per SD) 0.92 (0.83–1.01)
Yes
 Q1 (−10.5, −4.9) 4,323 15 1.00
 Q2 (−4.9, −2.3) 5,829 5 0.23 (0.08–0.65)
 Q3 (−2.3,1.0) 6,618 23 1.02 (0.47–2.20)
 Q4 (1.0,31.6) 7,494 24 0.98 (0.36–2.64)
Ptrend 0.42
Continuous scale (per SD) 1.14 (0.68–1.90)
P heterogeneity 0.25
a

Adjusted for age, sex, dialect, year of interview, education level, physical activity, family history of colorectal cancer, total energy intake, history of type 2 diabetes, BMI level, smoking status, and alcohol consumption, if applicable.

b

SD, standard deviation.